NFX-179 gel

DRUG2 trials

Sponsors

NFlection Therapeutics, Inc.

Conditions

Cutaneous NeurofibromaNeurofibromatosis 1

Phase 2

NFX-179 Topical Gel Treatment in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)

CompletedNCT04435665

NFlection Therapeutics, Inc.Cutaneous Neurofibroma, Neurofibromatosis 1

Start: 2020-08-21End: 2021-04-14Updated: 2022-08-09

NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)

CompletedNCT05005845

NFlection Therapeutics, Inc.Cutaneous Neurofibroma, Neurofibromatosis 1

Start: 2021-09-29End: 2023-10-02Updated: 2026-02-17